Visceral leishmaniasis and Coombs' positive hemolytic anemia: A rare association in an infant treated with liposomal amphotericin B

Turkish Journal of Pediatrics

Volumn 44, Issue 4, 2002, Pages 354-356

  Dilber, Embiya ^a   Erduran, Erol ^a   Işik, Yesamin ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Coombs' positive hemolytic anemia; Liposomal amphotericin B; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIMONY; METHYLPREDNISOLONE;

ANEMIA; ARTICLE; CASE REPORT; COMORBIDITY; COOMBS TEST; FEMALE; FEVER; HEMOLYTIC ANEMIA; HEPATOSPLENOMEGALY; HUMAN; HYPERGAMMAGLOBULINEMIA; INFANT; LEUKOPENIA; PROTOZOAL INFECTION; SIDE EFFECT; THROMBOCYTOPENIA; VISCERAL LEISHMANIASIS;

AMPHOTERICIN B; ANEMIA, HEMOLYTIC; ANTIPROTOZOAL AGENTS; COOMBS' TEST; FEMALE; HUMANS; INFANT; LEISHMANIASIS, VISCERAL; LIPOSOMES; TREATMENT OUTCOME;

EID: 0036807916     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Pearson RD, Sausa AQ. Clinical spectrum of leishmaniasis. Clin Infect Dis 1996; 22: 1-13.
2. Miescher PA, Belehu A. Leishmaniasis: hematologic aspects. Semin Hematol 1982; 19: 93-99.
3. Woodruff AW, Topley E, Knight R, Downie CG. The anemia of Kala Azar. Br J Haematol 1972; 22: 319-329.
4. Sundar S, Agrawal NK, Sinha PR, Horwith GS, Murray HW. Short-course low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony. Ann Intern Med 1997; 127: 133-137.
5. Mishra Mm, Biswas UK, Jha DN, Khan AB. Amphotericin versus pentamidine in antimony unresponsive kala azar. Lancet 1992; 340: 1256-1257.
6. Jha TK, Gri YN, Singh TK, Jha S. Use of amphotericin B in drug-resistant cases of visceral leishmaniasis in north Bihar, India. Am J Trop Med Hyg 1995; 52: 536-538.
7. Berman JD, Hanson WL, Chapman WL, Alving CR, Lopez BG. Antileishmanial activity of liposome-encapsulated amphotericin B in hamster and monkeys. Antimicrob Agents Chemother 1986; 30: 847-851.
8. Seaman J, Boer C, Wilkinson R, et al. Liposomal amphotericin B (Ambisome) in the treatment of complicated Kala Azar under the field conditions. CID 1995; 21. 188-193.
9. Davidson RN, Di Martio L, Gradoni L, et al. Liposomal amphotericin B (Ambisome) in Mediterranean visceral leishmaniasis: a multi-center trial. Q J Med 1994; 87: 75-81.
10. Croft SL, Davidson RN, Thornton EA. Liposomal amphotericin B in the treatment of visceral leishmaniasis. JAC 1991; 28 (Suppl): 111-118.
11. Erduran E, Aslan Y, Mocan H, Gedik Y, Anyaci FM, Ökten A. Reversible myelodysplasia due to kala-azar. Turk J Med Sci 1996; 26: 511-513.
12. Gagnaire MH, Galambrun C, Stéphan JL. Hemophagocytic syndrome. A misleading complication of visceral leishmaniasis in children-a series of 12 cases. Pediatrics 2000; 106: e58.
13. Hiçsönmez G, Özsoylu S. Kala-azar in childhood. A survery of clinical and laboratory findings and prognosis in 44 childhood cases. Clin Pediatr 1972; 11: 465-467.
14. Mocan H, Gedik Y, Ökten A, Erduran E, Gacar N. Kala Azar in Trabzon (Eastren Black Sea) region of Turkey. Indian J Pediatr 1993; 60: 775-778.